DK129089A - Fremgangsmaade til fremstilling af vaekstfaktor - Google Patents

Fremgangsmaade til fremstilling af vaekstfaktor

Info

Publication number
DK129089A
DK129089A DK129089A DK129089A DK129089A DK 129089 A DK129089 A DK 129089A DK 129089 A DK129089 A DK 129089A DK 129089 A DK129089 A DK 129089A DK 129089 A DK129089 A DK 129089A
Authority
DK
Denmark
Prior art keywords
ngf
growth factor
purification
cation exchange
exchange chromatography
Prior art date
Application number
DK129089A
Other languages
English (en)
Other versions
DK129089D0 (da
Inventor
Valle Francesco Della
Lanfranco Callegaro
Silvana Lorenzi
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of DK129089D0 publication Critical patent/DK129089D0/da
Publication of DK129089A publication Critical patent/DK129089A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK129089A 1988-03-18 1989-03-16 Fremgangsmaade til fremstilling af vaekstfaktor DK129089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47745/88A IT1219874B (it) 1988-03-18 1988-03-18 Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
DK129089D0 DK129089D0 (da) 1989-03-16
DK129089A true DK129089A (da) 1989-09-19

Family

ID=11262248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK129089A DK129089A (da) 1988-03-18 1989-03-16 Fremgangsmaade til fremstilling af vaekstfaktor

Country Status (10)

Country Link
US (1) US5210185A (da)
EP (1) EP0333574B1 (da)
JP (1) JP2798413B2 (da)
AT (1) ATE111740T1 (da)
AU (1) AU627717B2 (da)
CA (1) CA1339791C (da)
DE (1) DE68918312T2 (da)
DK (1) DK129089A (da)
IT (1) IT1219874B (da)
ZA (1) ZA891962B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) * 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
IT1239270B (it) * 1990-02-27 1993-10-01 Fidia Spa Metodo per la determinazione quantitativa della forma biologicamente attiva del fattore di crescita nervoso umano in liquidi proteici
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5986070A (en) * 1990-04-06 1999-11-16 Amgen Inc. Production of biologically active NGF proteins
JPH04119399A (ja) * 1990-09-11 1992-04-20 Kenwood Corp カラオケ装置
GB9111885D0 (en) * 1991-06-03 1991-07-24 Erba Carlo Spa Nerve growth factor for use in the prevention and treatment of viral infections
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
US5885584A (en) * 1991-08-05 1999-03-23 Boehringer Mannheim Gmbh Regeneration of oligodendrocytes
CH684741A5 (de) * 1992-06-11 1994-12-15 Lucchini Lab Sa Verfahren zur Herstellung eines Extraktes.
RU2073518C1 (ru) * 1993-06-17 1997-02-20 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, восстанавливающее функцию сетчатой оболочки глаза
US6277828B1 (en) * 1993-08-20 2001-08-21 Syntex (U.S.A.) Inc. Pharmaceutical formulations of nerve growth factor
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
NZ335207A (en) 1996-11-15 2000-09-29 Genentech Inc Process to isolate recombinant human neurotrophin using hydrophobic chromatography resin
US7282482B2 (en) 1998-04-08 2007-10-16 The Regents Of The University Of California NGF for the prevention of demyelination in the nervous system
BRPI9910332B8 (pt) * 1998-05-06 2021-05-25 Genentech Inc método para purificação de um polipeptídio a partir de uma composição
US7273618B2 (en) 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
DE60139874D1 (de) * 2000-07-28 2009-10-22 Christopher J Murphy Medium für transplantat
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
WO2004080960A2 (en) 2003-03-06 2004-09-23 Neose Technologies Inc. Methods and compositions for the enzymatic synthesis of gangliosides
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
CN105315323A (zh) 2007-10-30 2016-02-10 健泰科生物技术公司 通过阳离子交换层析进行的抗体纯化
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
IT201700066486A1 (it) * 2017-06-15 2018-12-15 Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologn A Siero sanguigno per uso nel trattamento di patologie neurodegenerative oftalmologiche

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407744A (en) * 1977-11-23 1983-10-04 Young David M Process for obtaining nerve growth factor
US4185095A (en) * 1977-11-23 1980-01-22 The Massachusetts General Hospital Nerve growth factor
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
EP0121388B1 (en) * 1983-03-30 1990-06-13 Lilly Industries Limited Immunoglobulin conjugates
US4662884A (en) * 1984-04-25 1987-05-05 University Of Utah Research Foundation Prostheses and methods for promoting nerve regeneration
IL83398A0 (en) * 1986-08-07 1987-12-31 Fidia Spa Novel neuronotrophic factor

Also Published As

Publication number Publication date
DK129089D0 (da) 1989-03-16
IT1219874B (it) 1990-05-24
AU3143589A (en) 1989-09-21
DE68918312D1 (de) 1994-10-27
ZA891962B (en) 1989-11-29
IT8847745A0 (it) 1988-03-18
EP0333574B1 (en) 1994-09-21
ATE111740T1 (de) 1994-10-15
JP2798413B2 (ja) 1998-09-17
AU627717B2 (en) 1992-09-03
EP0333574A2 (en) 1989-09-20
DE68918312T2 (de) 1995-03-16
EP0333574A3 (en) 1990-05-30
CA1339791C (en) 1998-03-31
JPH0228199A (ja) 1990-01-30
US5210185A (en) 1993-05-11

Similar Documents

Publication Publication Date Title
DK129089D0 (da) Fremgangsmaade til fremstilling af vaekstfaktor
FI884051L (fi) Menetelmä stabiloitujen humaaniproteiinivalmisteiden valmistamiseksi
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
EP0116446A2 (en) Hybridoma cell line and its monoclonal antibody to erythropoletin
HU9201551D0 (en) Method for producing biologically active compounds
RU93005051A (ru) Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации
FI103974B1 (fi) Menetelmä proteiinin puhdistamiseksi
ATE156360T1 (de) Verfahren zur herstellung eines konzentrates von blutgerinnungsfaktor xi mit hoher spezifischer aktivität zur therapeutischen verwendung
DK0722951T3 (da) Fremgangsmåde til fremstilling af TGF-beta
NO904927L (no) Fremstilling og rensing av rekombinant human interleukin-3 og muteiner derav.
EP0087686A3 (en) Homogeneous human immune interferon and process therefor
ES2049021T3 (es) Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.
MA20481A1 (fr) Acides hydro-5,6-4 cyclopenta[b] thiophenecarboxyliques-6 , procedes de preparations
IT1135153B (it) Processo per rendere incoagulabile il sangue mediante enzimi proteolitici e uso del sangue incoagulabile per produrre un concentrato proteico da sangue intero
RO102778A2 (ro) Procedeu de obtinere a serului anti-transferina umana
PL262638A1 (en) Adjustment system for proportioning of liquid,especially for inlet manifold of compression-ignition engine

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment